Liz Highleyman

Low-barrier care and access to multiple services in one place improves outcomes for people experiencing homelessness or unstable housing.

An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.

Some people with blood cancers, however, may not be as well protected.

The updates include new information on optimizing therapy, dealing with virological failure and managing opportunistic infections.

The protein subunit vaccine provides 100% protection against moderate or severe disease, hospitalization and death.

Alzheimer’s advocates laud the approval of Aduhelm, but experts raise questions about its effectiveness and cost.

The Epclusa and Mavyret combination pills are now indicated for kids as young as age 3.

Pioneering HIV doctor Paul Volberding and veteran activist Gregg Gonsalves reflect on the legacy of AIDS and its implications for COVID-19.

The new numbers are encouraging but Black and Latino people continue to be disproportionately affected by HIV.

Several formulations of generic Truvada are now available at a lower cost.

However, other malignancies caused by human papillomavirus, including anal and oral cancers, are on the rise.

The Pfizer-BioNTech vaccine was 100% effective in a study of adolescents; trials for younger children are now underway.

An oncolytic virus that kills cancer cells and triggers immune responses against tumors shows promise for children with brain cancer.

Rates of chlamydia, gonorrhea and syphilis increased in 2019, and the COVID-19 pandemic could make matters worse.

The CDC and FDA confirmed that the vaccine is safe, and said the recent pause should be lifted for all groups.